Neuroregulation of nonexercise activity thermogenesis and obesity resistance

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 294, Issue 3, 2008, Pages

  Kotz, Catherine M ^a,b,c   Teske, Jennifer A ^c   Billington, Charles J ^a,b,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Minnesota   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Agouti related protein; Energy expenditure; Ghrelin; Neuromedin U; Orexin; Spontaneous physical activity

Indexed keywords

AGOUTI RELATED PROTEIN; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; ESTROGEN; GHRELIN; LEPTIN; NEUROMEDIN U; NEUROPEPTIDE Y; OREXIN A;

CALORIC VESTIBULAR TEST; DISEASE PREDISPOSITION; ENERGY BALANCE; ENERGY COST; HUMAN; HUMAN TISSUE; NEUROMODULATION; NONEXERCISE ACTIVITY THERMOGENESIS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; STRAIN DIFFERENCE; THERMOGENESIS; WEIGHT GAIN;

ANIMALS; BODY TEMPERATURE REGULATION; BODY WEIGHT; BRAIN; ENERGY INTAKE; HUMANS; MOTOR ACTIVITY; OBESITY;

EID: 40449130442     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00095.2007     Document Type: Review

References (164)

1. Adriani W, Felici A, Sargolini F, Roullet P, Usiello A, Oliverio A, Mele A. N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes. Exp Brain Res 123: 52-59, 1998.
2. Amalric M, Koob GF. Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. Prog Brain Res 99: 209-226, 1993.
3. Arch JR, Hislop D, Wang SJ, Speakman JR. Some mathematical and technical issues in the measurement and interpretation of open-circuit indirect calorimetry in small animals. Int J Obes (Lond) 30: 1322-1331, 2006.
4. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120: 337-345, 2001.
5. Backberg M, Hervieu G, Wilson S, Meister B. Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake. Eur J Neurosci 15: 315-328, 2002.
6. Baldo BA, Kelley AE. Amylin infusion into rat nucleus accumbens potently depresses motor activity and ingestive behavior. Am J Physiol Regul Integr Comp Physiol 281: R1232-R1242, 2001.
7. Bates SH, Dundon TA, Seifert M, Carlson M, Maratos-Flier E, Myers MG Jr. LRb-STAT3 signaling is required for the neuroendocrine regulation of energy expenditure by leptin. Diabetes 53: 3067-3073, 2004.
8. Bathalon GP, Hays NP, McCrory MA, Vinken AG, Tucker KL, Greenberg AS, Castaneda C, Roberts SB. The energy expenditure of postmenopausal women classified as restrained or unrestrained eaters. Eur J Clin Nutr 55: 1059-1067, 2001.
9. Bayer L, Mairet-Coello G, Risold PY, Griffond B. Orexin/hypocretin neurons: chemical phenotype and possible interactions with melanin- concentrating hormone neurons. Regul Pept 104: 33-39, 2002.
10. Belcheva I, Belcheva S, Petkov VV, Petkov VD. Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala. Neuropharmacology 33: 995-1002, 1994.
11. Belke TW. Responding for sucrose and wheel-running reinforcement: effect of pre-running. Behav Processes 71: 1-7, 2006.
12. Belke TW, McLaughlin RJ. Habituation contributes to the decline in wheel running within wheel-running reinforcement periods. Behav Processes 68: 107-115, 2005.
13. Belke TW, Oldford AC, Forgie MY, Beye JA. Responding for sucrose and wheel-running reinforcement: effect of D-amphetamine. Behav Pharmacol 16: 219-225, 2005.
14. Belke TW, Wagner JP. The reinforcing property and the rewarding aftereffect of wheel running in rats: a combination of two paradigms. Behav Processes 68: 165-172, 2005.
15. Beninger RJ. The role of dopamine in locomotor activity and learning. Brain Res 287: 173-196, 1983.
16. Bernard R, Lydic R, Baghdoyan HA. Hypocretin-1 activates G proteins in arousal-related brainstem nuclei of rat. Neuroreport 13: 447-450, 2002.
17. Bittencourt JC, Elias CF. Melanin-concentrating hormone and neuropeptide EI projections from the lateral hypothalamic area and zona incerta to the medial septal nucleus and spinal cord: a study using multiple neuronal tracers. Brain Res 805: 1-19, 1998.
18. Blanchong JA, McElhinny TL, Mahoney MM, Smale L. Nocturnal and diurnal rhythms in the unstriped Nile rat, Arvicanthis niloticus. J Biol Rhythms 14: 364-377, 1999.
19. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49: 589-601, 2006.
20. Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T. The neuropeptide Y/agouti gene-related protein (AgRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 95: 15043-15048, 1998.
21. Brown RE, Sergeeva OA, Eriksson KS, Haas HL. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J Neurosci 22: 8850-8859, 2002.
22. Brownlow BS, Petro A, Feinglos MN, Surwit RS. The role of motor activity in diet-induced obesity in C57BL/6J mice. Physiol Behav 60: 37-41, 1996.
23. Burghardt PR, Fulk LJ, Hand GA, Wilson MA. The effects of chronic treadmill and wheel running on behavior in rats. Brain Res 1019: 84-96, 2004.
24. Burleson MH, Malarkey WB, Cacioppo JT, Poehlmann KM, Kiecolt-Glaser JK, Berntson GG, Glaser R. Postmenopausal hormone replacement: effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors. Psychosom Med 60: 17-25, 1998.
25. Butler PD, Weiss JM, Stout JC, Nemeroff CB. Corticotropin- releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 10: 176-183, 1990.
26. Carlsson A. On the neuronal circuitries and neurotransmitters involved in the control of locomotor activity. J Neural Transm Suppl 40: 1-12, 1993.
27. Casper RC. The 'drive for activity' and "restlessness" in anorexia nervosa: potential pathways. J Affect Disord 92: 99-107, 2006.
28. Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan XM, Ye Z, Nargund RP, Smith RG, Van der Ploeg LH, Howard AD, MacNeil DJ, Qian S. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145: 2607-2612, 2004.
29. Coppari R, Ichinose M, Lee CE, Pullen AE, Kenny CD, McGovern RA, Tang V, Liu SM, Ludwig T, Chua SC Jr, Lowell BB, and Elmquist JK. The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab 1: 63-72, 2005.
30. Crawley JN. Cholecystokinin modulates dopamine-mediated behaviors. Differential actions in medial posterior versus anterior nucleus accumbens. Ann NY Acad Sci 713: 138-142, 1994.
31. Crawley JN, Stivers JA, Blumstein LK, Paul SM. Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence. J Neurosci 5: 1972-1983, 1985.
32. Currie PJ, Coscina DV. Regional hypothalamic differences in neuropeptide Y-induced feeding and energy substrate utilization. Brain Res 737: 238-242, 1996.
33. Dahmen N, Bierbrauer J, Kasten M. Increased prevalence of obesity in narcoleptic patients and relatives. Eur Arch Psychiatry Clin Neurosci 251: 85-89, 2001.
34. David HN, Ansseau M, Abraini JH. Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals. Brain Res Brain Res Rev 50: 336-360, 2005.
35. Day DE, Bartness TJ. Agouti-related protein increases food hoarding more than food intake in Siberian hamsters. Am J Physiol Regul Integr Comp Physiol 286: R38-R45, 2004.
36. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FSn Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95: 322-327, 1998.
37. de Lecea L, Sutcliffe JG, Fabre V. Hypocretins/orexins as integrators of physiological information: lessons from mutant animals. Neuropeptides 36: 85-95, 2002.
38. Diamant M, Kashtanov SI, Fodor M, de Wied D. Corticotropin- releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats. Neuroendocrinology 56: 750-760, 1992.
39. Dixon DP, Ackert AM, Eckel LA. Development of, and recovery from, activity-based anorexia in female rats. Physiol Behav 80: 273-279, 2003.
40. Domin J, Steel JH, Adolphus N, Burrin JM, Leonhardt U, Polak JM, Bloom SR. The anterior pituitary content of neuromedin U-like immunoreactivity is altered by thyrotrophin-releasing hormone and thyroid hormone status in the rat. J Endocrinol 122: 471-476, 1989.
41. Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J, Tatro JB, Hoffman GE, Ollmann MM, Barsh GS, Sakurai T, Yanagisawa M, Elmquist JK. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 402: 442-459, 1998.
42. Fong TM, Mao C, MacNeil T, Kalyani R, Smith T, Weinberg D, Tota MR, Van der Ploeg LH. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem Biophys Res Commun 237: 629-631, 1997.
43. Freymond D, Larson K, Bogardus C, Ravussin E. Energy expenditure during normo- and overfeeding in peripubertal children of lean and obese Pima Indians. Am J Physiol Endocrinol Metab 257: E647-E653, 1989.
44. Gammie SC, Hasen NS, Rhodes JS, Girard I, Garland T Jr. Predatory aggression, but not maternal or intermale aggression, is associated with high voluntary wheel-running behavior in mice. Horm Behav 44: 209-221, 2003.
45. Gartlon J, Szekeres P, Pullen M, Sarau HM, Aiyar N, Shabon U, Michalovich D, Steplewski K, Ellis C, Elshourbagy N, Duxon M, Ashmeade TE, Harrison DC, Murdock P, Wilson S, Ennaceur A, Atkins A, Heidbreder C, Hagan JJ, Hunter AJ, Jones DN. Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats. Psychopharmacology (Berl) 177: 1-14, 2004.
46. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84: 488-495, 1973.
47. Gibbs J, Young RC, Smith GP. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 245: 323-325, 1973.
48. Gorzek JF, Hendrickson KC, Forstner JP, Rixen JL, Moran AL, Lowe DA. Estradiol and tamoxifen reverse ovariectomy-induced physical inactivity in mice. Med Sci Sports Exerc 39: 248-256, 2007.
49. Greco MA, Shiromani PJ. Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats. Brain Res Mol Brain Res 88: 176-182, 2001.
50. Greenwood BN, Foley TE, Burhans D, Maier SF, Fleshner M. The consequences of uncontrollable stress are sensitive to duration of prior wheel running. Brain Res 1033: 164-178, 2005.
51. 1b-adrenergic receptor mRNA in the rat raphe nuclei. Biol Psychiatry 57: 559-568, 2005.
52. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van der Ploeg LH, Howard AD. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 48: 23-29, 1997.
53. Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Routledge C, Hemmati P, Munton RP, Ashmeade TE, Shah AS, Hatcher JP, Hatcher PD, Jones DN, Smith MI, Piper DC, Hunter AJ, Porter RA, Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 96: 10911-10916, 1999.
54. Hagan MM, Rushing PA, Pritchard LM, Schwartz MW, Strack AM, Van Der Ploeg LH, Woods SC, Seeley RJ. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am J Physiol Regul Integr Comp Physiol 279: R47-R52, 2000.
55. Hanada R, Nakazato M, Murakami N, Sakihara S, Yoshimatsu H, Toshinai K, Hanada T, Suda T, Kangawa K, Matsukura S, Sakata T. A role for neuromedin U in stress response. Biochem Biophys Res Commun 289: 225-228, 2001.
56. Hanada R, Teranishi H, Pearson JT, Kurokawa M, Hosoda H, Fukushima N, Fukue Y, Serino R, Fujihara H, Ueta Y, Ikawa M, Okabe M, Murakami N, Shirai M, Yoshimatsu H, Kangawa K, Kojima M. Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway. Nat Med 10: 1067-1073, 2004.
57. Hanada T, Date Y, Shimbara T, Sakihara S, Murakami N, Hayashi Y, Kanai Y, Suda T, Kangawa K, Nakazato M. Central actions of neuromedin U via corticotropin-releasing hormone. Biochem Biophys Res Commun 311: 954-958, 2003.
58. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30: 345-354, 2001.
59. Hervieu GJ, Cluderay JE, Harrison DC, Roberts JC, Leslie RA. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 103: 777-797, 2001.
60. 2 consumption; opposite effects of leptin and etomoxir on respiratory quotient in mice. Obesity (Silver Spring) 14: 673-682, 2006.
61. Holahan MR, Kalin NH, Kelley AE. Microinfusion of corticotropin-releasing factor into the nucleus accumbens shell results in increased behavioral arousal and oral motor activity. Psychopharmacology (Berl) 130: 189-196, 1997.
62. Howard AD, Wang R, Pong SS, Mellin TN, Strack A, Guan XM, Zeng Z, Williams DL Jr, Feighner SD, Nunes CN, Murphy B, Stair JN, Yu H, Jiang Q, Clements MK, Tan CP, McKee KK, Hreniuk DL, McDonald TP, Lynch KR, Evans JF, Austin CP, Caskey CT, Van der Ploeg LH, Liu Q. Identification of receptors for neuromedin U and its role in feeding. Nature 406: 70-74, 2000.
63. Ivanov TR, Lawrence CB, Stanley PJ, Luckman SM. Evaluation of neuromedin U actions in energy homeostasis and pituitary function. Endocrinology 143: 3813-3821, 2002.
64. Jaszberenyi M, Bujdoso E, Bagosi Z, Telegdy G. Mediation of the behavioral, endocrine and thermoregulatory actions of ghrelin. Horm Behav 50: 266-273, 2006.
65. Jerlhag E, Egecioglu E, Dickson SL, Andersson M, Svensson L, Engel JA. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol 11: 45-54, 2006.
66. Jolicoeur FB, Michaud JN, Rivest R, Menard D, Gaudin D, Fournier A, St-Pierre S. Neurobehavioral profile of neuropeptide Y. Brain Res Bull 26: 265-268, 1991.
67. Jones DN, Gartlon J, Parker F, Taylor SG, Routledge C, Hemmati P, Munton RP, Ashmeade TE, Hatcher JP, Johns A, Porter RA, Hagan JJ, Hunter AJ, Upton N. Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity. Psychopharmacology (Berl) 153: 210-218, 2001.
68. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97: 12735-12740, 2000.
69. Kalivas PW, Duffy P, Latimer LG. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther 242: 757-763, 1987.
70. Kalivas PW, Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16: 223-244, 1991.
71. Kapas L, Obal F Jr, Alfoldi P, Rubicsek G, Penke B, Obal F. Effects of nocturnal intraperitoneal administration of cholecystokinin in rats: simultaneous increase in sleep, increase in EEG slow-wave activity, reduction of motor activity, suppression of eating, and decrease in brain temperature. Brain Res 438: 155-164, 1988.
72. Kiwaki K, Kotz CM, Wang C, Lanningham-Foster L, Levine JA. Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats. Am J Physiol Endocrinol Metab 286: E551-E559, 2004.
73. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660, 1999.
74. Koob GF, Bloom FE. Corticotropin-releasing factor and behavior. Fed Proc 44: 259-263, 1985.
75. Koob GF, Swerdlow N, Seeligson M, Eaves M, Sutton R, Rivier J, Vale W. Effects of α-flupenthixol and naloxone on CRF-induced locomotor activation. Neuroendocrinology 39: 459-464, 1984.
76. Koob GF, Thatcher-Britton K. Stimulant and anxiogenic effects of corticotropin releasing factor. Prog Clin Biol Res 192: 499-506, 1985.
77. Kotagal S, Krahn LE, Slocumb N. A putative link between childhood narcolepsy and obesity. Sleep Med 5: 147-150, 2004.
78. Kotz CM. Integration of feeding and spontaneous physical activity: role for orexin. Physiol Behav 88: 294-301, 2006.
79. Kotz CM, Teske JA, Levine JA, Wang C. Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul Pept 104: 27-32, 2002.
80. Kotz CM, Wang C, Teske JA, Thorpe AJ, Novak CM, Kiwaki K, Levine JA. Orexin A mediation of time spent moving in rats: neural mechanisms. Neuroscience 142: 29-36, 2006.
81. Kowalski TJ, Spar BD, Markowitz L, Maguire M, Golovko A, Yang S, Farley C, Cook JA, Tetzloff G, Hoos L, Del Vecchio RA, Kazdoba TM, McCool MF, Hwa JJ, Hyde LA, Davis H, Vassileva G, Hedrick JA, Gustafson EL. Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. J Endocrinol 185: 151-164, 2005.
82. Krahn DD, Gosnell BA, Levine AS, Morley JE. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res 443: 63-69, 1988.
83. Kulkosky PJ, Glazner GW, Moore HD, Low CA, Woods SC. Neuropeptide Y: behavioral effects in the golden hamster. Peptides 9: 1389-1393, 1988.
84. Laposky AD, Shelton J, Bass J, Dugovic C, Perrino N, Turek FW. Altered sleep regulation in leptin-deficient mice. Am J Physiol Regul Integr Comp Physiol 290: R894-R903, 2006.
85. Leibowitz SF, Hoebel BG. Behavioral neuroscience of obesity. In: Handbook of Obesity, edited by Bray GA, Bouchard C, and James WPJ. New York: Dekker, 1998, p. 313-358.
86. Levin BE, Dunn-Meynell AA, Balkan B, Keesey RE. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 273: R725-R730, 1997.
87. Levine JA, Eberhardt NL, Jensen MD. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 283: 212-214, 1999.
88. Levine JA, Lanningham-Foster LM, McCrady SK, Krizan AC, Olson LR, Kane PH, Jensen MD, Clark MM. Interindividual variation in posture allocation: possible role in human obesity. Science 307: 584-586, 2005.
89. Levine JA, Schleusner SJ, Jensen MD. Energy expenditure of nonexercise activity. Am J Clin Nutr 72: 1451-1454, 2000.
90. Levine JA, Vander Weg MW, Hill JO, Klesges RC. Non-exercise activity thermogenesis: the crouching tiger hidden dragon of societal weight gain. Arterioscler Thromb Vasc Biol 26: 729-736, 2006.
91. Lubkin M, Stricker-Krongrad A. Independent feeding and metabolic actions of orexins in mice. Biochem Biophys Res Commun 253: 241-245, 1998.
92. MacLean PS, Higgins JA, Johnson GC, Fleming-Elder BK, Donahoo WT, Melanson EL, Hill JO. Enhanced metabolic efficiency contributes to weight regain after weight loss in obesity-prone rats. Am J Physiol Regul Integr Comp Physiol 287: R1306-R1315, 2004.
93. Manini TM, Everhart JE, Patel KV, Schoeller DA, Colbert LH, Visser M, Tylavsky F, Bauer DC, Goodpaster BH, Harris TB. Daily activity energy expenditure and mortality among older adults. JAMA 296: 171-179, 2006.
94. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435: 6-25, 2001.
95. Matsuda K, Miura T, Kaiya H, Maruyama K, Uchiyama M, Kangawa K, Shioda S. Stimulatory effect of n-octanoylated ghrelin on locomotor activity in the goldfish, Carassius auratus. Peptides 27: 1335-1340, 2006.
96. Matsuzaki I, Sakurai T, Kunii K, Nakamura T, Yanagisawa M, Goto K. Involvement of the serotonergic system in orexin-induced behavioral alterations in rats. Regul Pept 104: 119-123, 2002.
97. McGregor IS, Menendez JA, Atrens DM. Metabolic effects of neuropeptide Y injected into the sulcal prefrontal cortex. Brain Res Bull 24: 363-367, 1990.
98. Menendez JA, McGregor IS, Healey PA, Atrens DM, Leibowitz SF. Metabolic effects of neuropeptide Y injections into the paraventricular nucleus of the hypothalamus. Brain Res 516: 8-14, 1990.
99. Mondal MS, Date Y, Murakami N, Toshinai K, Shimbara T, Kangawa K, Nakazato M. Neuromedin U acts in the central nervous system to inhibit gastric acid secretion via CRH system. Am J Physiol Gastrointest Liver Physiol 284: G963-G969, 2003.
100. Monnikes H, Heymann-Monnikes I, Tache Y. CRF in the paraventricular nucleus of the hypothalamus induces dose-related behavioral profile in rats. Brain Res 574: 70-76, 1992.
101. Moore FL, Roberts J, Bevers J. Corticotropin-releasing factor (CRF) stimulates locomotor activity in intact and hypophysectomized newts (Amphibia). J Exp Zool 231: 331-333, 1984.
102. Nakahara K, Hanada R, Murakami N, Teranishi H, Ohgusu H, Fukushima N, Moriyama M, Ida T, Kangawa K, Kojima M. The gut-brain peptide neuromedin U is involved in the mammalian circadian oscillator system. Biochem Biophys Res Commun 318: 156-161, 2004.
103. Nakazato M, Hanada R, Murakami N, Date Y, Mondal MS, Kojima M, Yoshimatsu H, Kangawa K, Matsukura S. Central effects of neuromedin U in the regulation of energy homeostasis. Biochem Biophys Res Commun 277: 191-194, 2000.
104. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409: 194-198, 2001.
105. Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanasigawa M, Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 827: 243-260, 1999.
106. Nijsen MJ, Croiset G, Diamant M, De Wied D, Wiegant VM. CRH signalling in the bed nucleus of the stria terminalis is involved in stress-induced cardiac vagal activation in conscious rats. Neuropsychopharmacology 24: 1-10, 2001.
107. Novak CM, Kotz CM, Levine JA. Central orexin sensitivity, physical activity, and obesity in diet-induced obese and diet-resistant rats. Am J Physiol Endocrinol Metab 290: E396-E403, 2006.
108. Novak CM, Zhang M, Levine JA. Neuromedin U in the paraventricular and arcuate hypothalamic nuclei increases non-exercise activity thermogenesis. J Neuroendocrinol 18: 594-601, 2006.
109. Novak CM, Zhang M, Levine JA. Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity. Brain Res 1169: 57-68, 2007.
110. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278: 135-138, 1997.
111. Onn SP, West AR, Grace AA. Dopamine-mediated regulation of striatal neuronal and network interactions. Trends Neurosci 23: S48-S56, 2000.
112. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic, 1990.
113. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543, 1995.
114. Peng MT, Kang M. Circadian rhythms and patterns of running-wheel activity, feeding and drinking behaviors of old male rats. Physiol Behav 33: 615-620, 1984.
115. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18: 9996-10015, 1998.
116. Pich EM, Agnati LF, Zini I, Marrama P, Carani C. Neuropeptide Y produces anxiolytic effects in spontaneously hypertensive rats. Peptides 14: 909-912, 1993.
117. Qian S, Chen H, Weingarth D, Trumbauer ME, Novi DE, Guan X, Yu H, Shen Z, Feng Y, Frazier E, Chen A, Camacho RE, Shearman LP, Gopal-Truter S, MacNeil DJ, Van der Ploeg LH, Marsh DJ. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol 22: 5027-5035, 2002.
118. Ravussin Physiology E. A NEAT way to control weight? Science 307: 530-531, 2005.
119. Ravussin E, Burnand B, Schutz Y, Jequier E. Energy expenditure before and during energy restriction in obese patients. Am J Clin Nutr 41: 753-759, 1985.
120. Ravussin E, Lillioja S, Anderson TE, Christin L, Bogardus C. Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber. J Clin Invest 78: 1568-1578, 1986.
121. Redlin U, Mrosovsky N. Nocturnal activity in a diurnal rodent (Arvicanthis niloticus): the importance of masking. J Biol Rhythms 19: 58-67, 2004.
122. Ricci MR, Levin BE. Ontogeny of diet-induced obesity in selectively bred Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 285: R610-R618, 2003.
123. Rojas-Ramirez JA, Crawley JN, Mendelson WB. Electroencephalographic analysis of the sleep-inducing actions of cholecystokinin. Neuropeptides 3: 129-138, 1982.
124. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585, 1998.
125. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585, 1998.
126. Satvat E, Eikelboom R. Dissociation of conditioned and unconditioned factors in the running-induced feeding suppression. Physiol Behav 89: 428-437, 2006.
127. Schoeller DA, Jefford G. Determinants of the energy costs of light activities: inferences for interpreting doubly labeled water data. Int J Obes Relat Metab Disord 26: 97-101, 2002.
128. Schuld A, Hebebrand J, Geller F, Pollmacher T. Increased body-mass index in patients with narcolepsy. Lancet 355: 1274-1275, 2000.
129. Seoane LM, Lopez M, Tovar S, Casanueva FF, Senaris R, Dieguez C. Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 144: 544-551, 2003.
130. Sherwin CM. Voluntary wheel running: a review and novel interpretation. Anim Behav 56: 11-27, 1998.
131. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50: 227-232, 2001.
132. Shousha S, Nakahara K, Miyazato M, Kangawa K, Murakami N. Endogenous neuromedin U has anorectic effects in the Japanese quail. Gen Comp Endocrinol 140: 156-163, 2005.
133. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R, Stark KL. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 11: 593-602, 1997.
134. Soar J, Hewson G, Leighton GE, Hill RG, Hughes J. L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity. Pharmacol Biochem Behav 33: 637-640, 1989.
135. Sun Y, Ahmed S, Smith RG. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23: 7973-7981, 2003.
136. Sunter D, Morgan I, Edwards CM, Dakin CL, Murphy KG, Gardiner J, Taheri S, Rayes E, Bloom SR. Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem. Brain Res 907: 27-34, 2001.
137. Suzuki R, Shimojima H, Funahashi H, Nakajo S, Yamada S, Guan JL, Tsurugano S, Uehara K, Takeyama Y, Kikuyama S, Shioda S. Orexin-1 receptor immunoreactivity in chemically identified target neurons in the rat hypothalamus. Neurosci Lett 324: 5-8, 2002.
138. Szentirmai E, Hajdu I, Obal F Jr, Krueger JM. Ghrelin-induced sleep responses in ad libitum fed and food-restricted rats. Brain Res 1088: 131-140, 2006.
139. Tang-Christensen M, Vrang N, Ortmann S, Bidlingmaier M, Horvath TL, Tschop M. Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology 145: 4645-4652, 2004.
140. Tazi A, Swerdlow NR, LeMoal M, Rivier J, Vale W, Koob GF. Behavioral activation by CRF: evidence for the involvement of the ventral forebrain. Life Sci 41: 41-49, 1987.
141. Tchernof A, Calles-Escandon J, Sites CK, Poehlman ET. Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy. Coron Artery Dis 9: 503-511, 1998.
142. Terao A, Apte-Deshpande A, Morairty S, Freund YR, Kilduff TS. Age-related decline in hypocretin (orexin) receptor 2 messenger RNA levels in the mouse brain. Neurosci Lett 332: 190-194, 2002.
143. Teske JA, Levine AS, Kuskowski M, Levine JA, Kotz CM. Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol 291: R889-R899, 2006.
144. Thorpe AJ, Kotz CM. Orexin A in the nucleus accumbens stimulates feeding and locomotor activity. Brain Res 1050: 156-162, 2005.
145. Thorpe AJ, Mullett MA, Wang C, Kotz CM. Peptides that regulate food intake: regional, metabolic, and circadian specificity of lateral hypothalamic orexin A feeding stimulation. Am J Physiol Regul Integr Comp Physiol 284: R1409-R1417, 2003.
146. Tou JC, Wade CE. Determinants affecting physical activity levels in animal models. Exp Biol Med (Maywood) 227: 587-600, 2002.
147. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, Guan XM. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438: 71-75, 1998.
148. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LHT, Guan XM. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438: 71-75, 1998.
149. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 407: 908-913, 2000.
150. Tschop M, Statnick MA, Suter TM, Heiman ML. GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein. Endocrinology 143: 558-568, 2002.
151. Vaccarino FJ. Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors. Neurosci Biobehav Rev 18: 207-214, 1994.
152. Vaccarino FJ, Rankin J. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function. Behav Neurosci 103: 831-836, 1989.
153. van den Pol AN, Ghosh PK, Liu RJ, Li Y, Aghajanian GK, Gao XB. Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus. J Physiol 541: 169-185, 2002.
154. Vanltallie TB. Resistance to weight gain during overfeeding: a NEAT explanation. Nutr Rev 59: 48-51, 2001.
155. Webb P, Annis JF, Troutman SJ Jr. Energy balance in man measured by direct and indirect calorimetry. Am J Clin Nutr 33: 1287-1298, 1980.
156. Wellman PJ, Davis KW, Nation JR. Augmentation of cocaine hyperactivity in rats by systemic ghrelin. Regul Pept 125: 151-154, 2005.
157. Widdowson EM, Edholm OG, Mc CR. The food intake and energy expenditure of cadets in training. Br J Nutr 8: 147-155, 1954.
158. Widerlov E, Kalivas PW, Lewis MH, Prange AJ Jr, Breese GR. Influence of cholecystokinin on central monoaminergic pathways. Regul Pept 6: 99-109, 1983.
159. Wortley KE, Anderson KD, Yasenchak J, Murphy A, Valenzuela D, Diano S, Yancopoulos GD, Wiegand SJ, Sleeman MW. Agouti-related protein-deficient mice display an age-related lean phenotype. Cell Metab 2: 421-427, 2005.
160. Wortley KE, del Rincon JP, Murray JD, Garcia K, Iida K, Thorner MO, Sleeman MW. Absence of ghrelin protects against early-onset obesity. J Clin Invest 115: 3573-3578, 2005.
161. Wren AM, Small CJ, Abbott CR, Jethwa PH, Kennedy AR, Murphy KG, Stanley SA, Zollner AN, Ghatei MA, Bloom SR. Hypothalamic actions of neuromedin U. Endocrinology 143: 4227-4234, 2002.
162. Yoshimichi G, Yoshimatsu H, Masaki T, Sakata T. Orexin-A regulates body temperature in coordination with arousal status. Exp Biol Med (Maywood) 226: 468-476, 2001.
163. Zurlo F, Ferraro RT, Fontvielle AM, Rising R, Bogardus C, Ravussin E. Spontaneous physical activity and obesity: cross-sectional and longitudinal studies in Pima Indians. Am J Physiol Endocrinol Metab 263: E296-E300, 1992.
164. Zurlo F, Ferraro RT, Fontvielle AM, Rising R, Bogardus C, Ravussin E. Spontaneous physical activity and obesity: cross-sectional and longitudinal studies in Pima Indians. Am J Physiol Endocrinol Metab 263: E296-E300, 1992.